Predicting the effect of SGLT2 inhibition on glycemic control in diabetes mellitus where clinical data remain scarce, e.g., elderly and pediatric patients, and patients with type 1 diabetes mellitus (Lu et al., 2014). The gene discussed is SLC5A2; the disease is diabetes mellitus.